Paolo Parini

“Paolo Parini was born in Rimini, Italy, in 1964. He gained his MD degree in 1990 at the Universita’ di Bologna, Italy, where he also obtained his specialization in Gastroenterology and Hepatology, in 1994. The same year Parini was registered as PhD-student at the Karolinska Institutet, Sweden, under the supervision of Prof Mats Rudling and Prof Bo Angelin. In 1999, he obtained his PhD defending a thesis entitled “Hormonal regulation of hepatic cholesterol and lipoprotein metabolism: effects of estrogen and growth hormone” and since then his research activities are focused on the different aspects of lipoprotein metabolism in humans and in preclinical models. Professor Parini’s postdoctoral activities have been performed at the Dept of Medicine, Karolinska Institutet, and in the lab of Prof Lawrence Rudel, Lipid Sciences, Wake Forest University School of Medicine Winston-Salem, NC, US. In 2006, he moved to the Dept of Laboratory Medicine, Karolinska Institutet, and created a research group together with Prof Mats Eriksson. From 2010 to 2016, Paolo Parini was the Director of the Division of Clinical Chemistry, Dept. of Laboratory Medicine, Karolinska Institutet. In 2011, he obtained the specialization in Clinical Chemistry (Swedish National Board of Health and Welfare) and in 2012 he become full professor in Clinical Chemistry at the Dept of Laboratory Medicine, Karolinska Institutet. Since 2015, his professorship became “translational” being located 50% at the Dept of Laboratory Medicine and 50% at the Dept of Medicine, Karolinska Institutet. Since January 2017, Professor Parini is also the Director of Research, Development, Education, and Innovation currently at the National and International Affairs of the Karolinska University Hospital, Sweden. He is member of the Faculty Council the Karolinska Institutet and member of the Scientific Committee of the Center E. Grossi Paoletti, Universita’ di Milano, Italy. Professor Parini has been visiting professor in 2022 and 2023 at he Division of Cardiovascular Medicine, Dept of Medicine, at Brigham and Women’s Hospital and at Harvard Medical School, Boston, USA, and visiting professor at the Department of Pharmacological and Biomolecular Sciences, University of Milano (2017 – 2019). Professor Parini served on the Society’s Executive Committee as Treasurer between 2018 and 2021. He has represented Sweden in the Steering Committee of the European Lipoprotein Club (2005-2010) and in the Steering Committee of the Scandinavian Society of Atherosclerosis Reseach (2008 – 2021). He has been the Chairman of the Scandinavian Society of Atherosclerosis Research between 2011 and 2015”